T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare T-Cell lymphoma: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called enasidenib in people with a rare type of T-cell lymphoma (AITL) that has a specific gene change (IDH2 mutation). The goal is to see if enasidenib, given alone or with another drug (rituximab), is safe and can shrink tumors. About 25 adults whose can…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:27 UTC
-
New hope for tough lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ST-001 in people with T-cell non-Hodgkin lymphoma that has returned or not responded to prior treatments. The main goals are to find the safest dose and to watch for side effects. About 46 participants will receive the drug through a…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Promising combo therapy targets tough lymphoma
Disease control Recruiting nowThis study tests adding the drug mogamulizumab to standard chemotherapy for people with aggressive T-cell lymphoma, a rare blood cancer. About 22 adults with newly diagnosed or returning lymphoma will receive the combination. The goal is to see if more patients achieve complete r…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goal is t…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with another drug (pembrolizumab), in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard treatments. The main goals are to check safety, find the bes…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope: drug may stop lymphoma relapse after transplant
Disease control Recruiting nowThis study tests whether the drug ruxolitinib, taken as a maintenance therapy after a stem cell transplant, can help prevent T-cell lymphoma from coming back and reduce the risk of graft-versus-host disease (GVHD), a common complication where donor cells attack the patient's body…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for kids with aggressive leukemia: trial tests powerful drug combos
Disease control Recruiting nowThis study is testing whether adding one of two targeted drugs, dasatinib or venetoclax, to standard chemotherapy can improve outcomes for children and young adults with newly diagnosed T-cell leukemia or lymphoma. The main goal is to see if more patients achieve a deep, early re…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC
-
Crushed cancer pill study aims to help kids who Can't swallow tablets
Knowledge-focused Recruiting nowThis study looks at how the body processes venetoclax when the tablet is crushed and mixed into a liquid for children and young adults with blood cancers like leukemia or lymphoma. About 30 participants who already take venetoclax this way will have their blood levels measured. T…
Matched conditions: T-CELL LYMPHOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC